QLT Announces Third Quarter Results for 2011
November 03, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Nov. 3, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is an ocular-focused company dedicated to the development and commercialization...
QLT to Report Third Quarter Financial Results on November 3, 2011
October 26, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Oct. 26, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced that it will release financial results for the third quarter ended September 30, 2011 on...
QLT to Present at the UBS Global Life Sciences Conference
September 19, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Sept. 19, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced that Bob Butchofsky, President and Chief Executive Officer, will be presenting at the...
QLT Receives Fast Track Designations for QLT091001 to Treat Both Leber Congenital Amaurosis and Retinitis Pigmentosa
September 14, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, Sept. 14, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced the Company's oral synthetic retinoid for retinal diseases, QLT091001, has been granted...
QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System
August 29, 2011 06:30 ET
|
QLT Inc.
First reported demonstration of a clinically significant, prolonged (4 weeks) reduction in intraocular pressure (IOP) in glaucoma with an extraocular, minimally-invasive sustained release...
QLT Announces Second Quarter Results for 2011
July 28, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, July 28, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the second quarter ended June 30, 2011....
QLT Announces Issuance of U.S. Patent for Use of QLT091001 in Treatment of Inherited or Age-Related Retinal Diseases
May 31, 2011 12:12 ET
|
QLT Inc.
VANCOUVER, British Columbia, May 31, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced the United States Patent and Trademark Office ("USPTO") has issued a key patent related...
QLT Announces First Quarter Results for 2011
May 05, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, May 5, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the first quarter ended March 31, 2011....
QLT Announces Positive Results From Phase 1b Trial of QLT091001 in Subjects With Leber Congenital Amaurosis
May 03, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, May 3, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX-V:QLT) ("QLT" or the "Company") announced today positive preliminary results from its Phase 1b proof-of-concept...
QLT Announces QLT091001 Presentation At ARVO
April 27, 2011 06:30 ET
|
QLT Inc.
VANCOUVER, British Columbia, April 27, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that preliminary results from the Leber Congenital Amaurosis...